Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ISOSORBIDE MONONITRATE Cause Multiple drug therapy? 22 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 22 reports of Multiple drug therapy have been filed in association with ISOSORBIDE MONONITRATE (Isosorbide Mononitrate). This represents 0.9% of all adverse event reports for ISOSORBIDE MONONITRATE.

22
Reports of Multiple drug therapy with ISOSORBIDE MONONITRATE
0.9%
of all ISOSORBIDE MONONITRATE reports
0
Deaths
22
Hospitalizations

How Dangerous Is Multiple drug therapy From ISOSORBIDE MONONITRATE?

Of the 22 reports, 22 (100.0%) required hospitalization, and 2 (9.1%) were considered life-threatening.

Is Multiple drug therapy Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ISOSORBIDE MONONITRATE. However, 22 reports have been filed with the FAERS database.

What Other Side Effects Does ISOSORBIDE MONONITRATE Cause?

Dizziness (554) Headache (500) Dyspnoea (462) Chest pain (458) Nausea (458) Fatigue (446) Diarrhoea (439) Pruritus (416) Myocardial infarction (409) Malaise (405)

What Other Drugs Cause Multiple drug therapy?

AMLODIPINE (136) LEVOTHYROXINE (133) FUROSEMIDE (132) ALBUTEROL (122) ACEBUTOLOL (104) OMEPRAZOLE (104) ACETAMINOPHEN (98) ASPIRIN (98) QUETIAPINE (97) AMITRIPTYLINE (84)

Which ISOSORBIDE MONONITRATE Alternatives Have Lower Multiple drug therapy Risk?

ISOSORBIDE MONONITRATE vs ISOTRETINOIN ISOSORBIDE MONONITRATE vs ISRADIPINE ISOSORBIDE MONONITRATE vs ISTRADEFYLLINE ISOSORBIDE MONONITRATE vs ITACITINIB ISOSORBIDE MONONITRATE vs ITRACONAZOLE

Related Pages

ISOSORBIDE MONONITRATE Full Profile All Multiple drug therapy Reports All Drugs Causing Multiple drug therapy ISOSORBIDE MONONITRATE Demographics